TSARG6 Activators
TSARG6 Activators are a collection of chemical compounds that serve to amplify the functional capabilities of TSARG6 through distinct and specific intracellular signaling pathways. Forskolin, for instance, by catalyzing an increase in cAMP, indirectly promotes the activation of TSARG6 by means of PKA-mediated phosphorylation events, which are likely to target proteins within TSARG6's signaling axis. Similarly, db-cAMP also raises cAMP levels, but as a more stable analog, ensuring prolonged PKAactivation and thus sustained support for TSARG6's pathway engagement. Ionomycin and A23187, both calcium ionophores, heighten intracellular calcium, a second messenger that can activate calcium-dependent kinases; these kinases are anticipated to phosphorylate proteins within the cascade that TSARG6 is engaged in, thereby culminating in its functional augmentation. Phorbol 12-myristate 13-acetate (PMA) and Epigallocatechin gallate (EGCG) work through the activation of PKC and inhibition of competitive protein kinases respectively, each potentially shifting the cellular signaling balance in favor of pathways that would enhance TSARG6 activity.
Furthermore, the inhibition of phosphodiesterase enzymes by compounds such as Sildenafil citrate, Vardenafil, Zaprinast, and Rolipram leads to increased levels of cyclic nucleotides (cGMP and cAMP) and activation of their respective protein kinases (PKG and PKA), which are posited to phosphorylate and thus activate proteins within TSARG6's pathway. LY294002, a PI3K inhibitor, could indirectly stimulate TSARG6 by rerouting signaling flux through compensatory pathways upon PI3K inhibition. Okadaic acid's inhibition of protein phosphatases 1 and 2A results in a phosphorylation-dominant cellular state that could enhance the phosphorylation and consequent activation of proteins upstream or within the TSARG6 signaling framework.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing the levels of cAMP within the cell. Elevated cAMP activates protein kinase A (PKA), which can phosphorylate various targets that may include proteins in the pathway that TSARG6 is a part of, leading to its activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which is involved in various signaling pathways. PKC can phosphorylate target proteins that could interact with or regulate TSARG6, resulting in its enhanced functional activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent protein kinases. These kinases could phosphorylate and thereby activate proteins within the signaling cascade that TSARG6 is involved in. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit several protein kinases and has been found to influence multiple signaling pathways. By inhibiting competitive pathways, EGCG could shift the balance towards the activation of pathways involving TSARG6. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable cAMP analog that directly activates PKA. The activation of PKA can lead to the phosphorylation of regulatory proteins in the pathway of TSARG6, thereby enhancing its activity. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Vardenafil, like sildenafil, inhibits PDE5 leading to increased cGMP levels, and thereby activation of PKG. PKG, in turn, can phosphorylate proteins within the signaling network of TSARG6, potentially enhancing its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can lead to the modulation of the AKT signaling pathway. By inhibiting PI3K, a compensatory upregulation of alternative pathways that involve TSARG6 activation could occur. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels of cellular proteins. This could result in the enhanced activity of kinases that phosphorylate proteins in the TSARG6 pathway. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, similar to ionomycin, raising intracellular calcium levels. This increase can activate calcium-dependent signaling pathways, which could include the pathway TSARG6 is part of, leading to its activation. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits PDE5 and PDE6, resulting in increased cGMP levels, which activate PKG. PKG then phosphorylates targets within the signaling networks that could include those regulating TSARG6, enhancing its activity. | ||||||